BIOBOT Surgical

BIOBOT Surgical develops and manufactures robotic systems for prostate biopsy and treatment. Their flagship product, the Mona Lisa system, provides urologists with robotic precision and enhanced visualization for percutaneous transperineal procedures, improving patient outcomes. The company has already deployed over 50 Mona Lisa robots globally, performing over 20,000 procedures.

Funding Round: Series B

Funding Amount: $18M

Date: 07-Mar-2024

Investors: Mr. Tony Tan, ZIG Ventures

Markets: Medtech, Robotics, Urology

HQ: Singapore, Singapore, Singapore

Founded: 2007

Website: https://www.biobotsurgical.com

LinkedIn: https://www.linkedin.com/company/biobot-surgical-pte-ltd

Twitter: https://twitter.com/biobotmonalisa

Instagram:

Facebook: https://www.facebook.com/biobotsurgical

Crunchbase: https://www.crunchbase.com/organization/biobot-surgical-pte-ltd?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase

Pitchbook: https://pitchbook.com/profiles/company/500626-36


Similar Startups


Leave a Comment

    🔷 Buy VC Database 🟩 Buy Startup Database 🎁 Get Free Sample

    Share this: